CLINICAL_TRIALS
trial_result
· 2026-08-18
Clinical Trial Results: Cardiac Allograft Vasculopathy Inhibition With Alirocumab [Phase 2]
Summary
Phase 2 trial evaluating alirocumab for inhibition of cardiac allograft vasculopathy; results completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Vasculopathy | Phase 2 | Status: COMPLETED | Results posted: 2026-08-18